![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 37, 26557-26562, September 10, 1999
From the Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104
| |
ABSTRACT |
|---|
|
|
|---|
Hyaluronan (HA), a long linear polymer composed
of alternating glucuronic acid and N-acetylglucosamine
residues, is an essential polysaccharide in vertebrates and a putative
virulence factor in certain microbes. All known HA synthases utilize
UDP-sugar precursors. Previous reports describing the HA synthase
enzymes from Streptococcus bacteria and mammals, however,
did not agree on the molecular directionality of polymer elongation. We
show here that a HA synthase, PmHAS, from Gram-negative P. multocida bacteria polymerizes the HA chain by the addition of
sugar units to the nonreducing terminus. Recombinant PmHAS will
elongate exogenous HA oligosaccharide acceptors to form long polymers
in vitro; thus far no other HA synthase has displayed this
capability. The directionality of synthesis was established
definitively by testing the ability of PmHAS to elongate defined
oligosaccharide derivatives. Analysis of the initial stages of
synthesis demonstrated that PmHAS added single monosaccharide units
sequentially. Apparently the fidelity of the individual sugar transfer
reactions is sufficient to generate the authentic repeating structure
of HA. Therefore, simultaneous addition of disaccharide block units is
not required as hypothesized in some recent models of polysaccharide
biosynthesis. PmHAS appears distinct from other known HA synthases
based on differences in sequence, topology in the membrane, and
putative reaction mechanism.
Polysaccharides are the most abundant biomaterials on earth, yet
many of the molecular details of their biosynthesis and function are
not clear. HA1 is a linear
polysaccharide of the glycosaminoglycan class composed of up to
thousands of HA is also made by certain microbes. Some bacterial pathogens, namely
Gram-negative Pasteurella multocida Type A and Gram-positive Streptococcus Group A and C, produce extracellular HA
capsules (3, 4); this coating protects the microbes from host defenses including complement and phagocytosis (5, 6). The Paramecium bursaria chlorella virus (PBCV-1) directs the algal host cells to
produce a HA surface coating early in infection, but the biological role of HA in the viral life cycle is not yet known (7).
The various HA synthases, the enzymes that polymerize HA, utilize
UDP-GlcUA and UDP-GlcNAc sugar nucleotide precursors in the presence of
a divalent Mn2+ or Mg2+ ion (7-9). The HA
synthase activity from all sources is localized in the membrane
fraction. The enzymes were all identified by molecular genetic means
due to the innate problems of membrane protein purification. In all
cases, a single species of polypeptide catalyzes the transfer of two
distinct sugars; in contrast, the vast majority of other known
glycosyltransferases transfer only one monosaccharide.
HasA (or SpHAS) from Group A Streptococcus pyogenes was the
first HA synthase to be described at the molecular level (10). The
various vertebrate homologs (Xenopus frog DG42 or XlHAS1; murine and human HAS1, HAS2, and HAS3) and the viral enzyme, A98R, are
quite similar at the amino acid level to certain regions of the HasA
polypeptide chain (~30% identity overall). At least 7 short motifs
(5-9 residues) interspersed throughout these enzymes are identical or
quite conserved. The evolutionary relationship among these HA synthases
from such dissimilar sources is not clear at present. The enzymes are
predicted to have a similar overall topology in the bilayer;
membrane-associated regions at the amino and the carboxyl termini flank
a large cytoplasmic central domain (~200 amino acids; reviewed in
Ref. 8). The amino-terminal region appears to contain two transmembrane
segments, whereas the carboxyl-terminal region appears to contain three
to five membrane-associated or transmembrane segments depending on the species. Very little of these HAS polypeptide chains are expected to be
exposed to the outside of the cell.
With respect to the reaction pathway utilized by this group of enzymes,
mixed findings have been reported from indirect experiments. The Group
A streptococcal enzyme was reported to add sugars to the nonreducing
terminus of the growing chain as determined by selective labeling and
degradation studies (11). Using a similar approach, however, two
laboratories working with the enzyme preparations from mammalian cells
concluded that the new sugars were added to the reducing end of the
nascent chain (12, 13). In comparing these various studies, the
analysis of the enzymatically released sugars from the streptococcal
system added more rigorous support for their interpretation (11). In
another type of experiment, HA made in mammalian cells was reported to
have a covalently attached UDP group as measured by an incorporation of
low amounts of radioactivity derived from 32P-labeled
UDP-sugar into an anionic polymer (14). These data implied that the
last sugar was transferred to the reducing end of the polymer. Thus it
remains unclear if these rather similar HAS polypeptides from
vertebrates and streptococci actually utilize different reaction pathways.
We recently reported the identification and molecular cloning of a
unique HA synthase, PmHAS, from the fowl cholera pathogen, Type A
P. multocida (15). Expression of this single 972-residue protein allowed the Escherichia coli host cells to produce
HA capsules in vivo; normally E. coli does not
make HA. Overall, the deduced PmHAS sequence is very different from the
other known HA synthases. There appear to be only two short potential
sequence motifs ((D/N)DGS(S/T); DSD(D/T)Y) in common between PmHAS and Group A HasA. Instead, a portion of the central region of the new
enzyme is more homologous to the amino termini of other bacterial glycosyltransferases that produce different capsular polysaccharides or
lipopolysaccharides. Furthermore, even though PmHAS is about twice as
long as any other HAS enzyme, it only has two predicted transmembrane-spanning helices separated by ~320 residues. Thus at
least a third of the polypeptide is predicted not to be in the cytoplasm.
In this report, definitive proof is presented that PmHAS adds sugars to
the nonreducing end of the growing polymer chain, in contrast to the
reports with mammalian enzymes. Furthermore, it is shown that the
correct monosaccharides are added sequentially in a stepwise fashion to
the nascent chain. This is the first direct demonstration of HA
polysaccharide polymerization in such a fashion.
All reagents were from Sigma or Fisher unless noted otherwise.
HA Synthase Isolation and Assays--
Membrane
preparations containing recombinant PmHAS (rPmHAS) (GenBankTM number
AF036004) were isolated from E. coli SURE(pPmHAS) as
described (15). Membrane preparations containing native PmHAS were
obtained from the P. multocida strain P-1059 (ATCC #15742) as described (9), except that 1 mM Acceptor Oligosaccharides--
Uronic acid was quantitated by
the carbazole method (17). Even-numbered HA oligosaccharides
((GlcNAc-GlcUA)n) were generated by degradation of HA (from
Group C Streptococcus) with either ovine testicular
hyaluronidase Type V (n = 2-5) or Streptomyces hyaluroniticus HA lyase (n = 2 or 3) in 30 mM sodium acetate, pH 5.2, at 30 °C overnight. The
latter enzyme employs an elimination mechanism to cleave the chain,
resulting in an unsaturated
Other oligosaccharides that are structurally similar to HA were also
tested in HAS assays. The structure of heparosan pentamer derived from
the E. coli K5 capsular polysaccharide is
(
Various oligosaccharides were radiolabeled by reduction with 4 to 6 equivalents of sodium borotritide (20 mM, NEN Life Science Products; 0.2 Ci/mmol) in 15 mM NaOH at 30 °C for 2 h (21). [3H]Oligosaccharides were desalted on a P-2
column in 0.2 M ammonium formate to remove unincorporated
tritium and lyophilized. Some labeled oligosaccharides were further
purified preparatively by paper chromatography with Whatman 1 developed
in pyridine/ethyl acetate/acetic acid/H2O (5:5:1:3) before
use as an acceptor.
Chromatographic Analyses of HA Synthase Reaction
Products--
Paper chromatography with Whatman No. 3M developed in
ethanol 1 M ammonium acetate, pH 5.5 (65:35), was used to
separate high molecular weight HA product (which remains at the origin)
from UDP-sugars and small acceptor oligosaccharides (22). In the conventional HAS assay, radioactive UDP-sugars are polymerized into HA.
To obtain the size distribution of the HA polymerization products, some
samples were also separated by gel filtration chromatography with
Sephacryl S-200 (Amersham Pharmacia Biotech) columns in 0.2 M NaCl, 5 mM Tris, pH 8. Columns were
calibrated with dextran standards. The identity of the polymer products
was assessed by sensitivity to specific HA lyase and the requirement
for the simultaneous presence of both UDP-sugar precursors during the
reaction. Thin layer chromatography (TLC) on high performance silica
plates with application zones (Whatman) utilizing butanol/acetic
acid/water (1.5:1:1 or 1.25:1:1) development solvent separated
3H-labeled oligosaccharides in reaction mixes. Radioactive
molecules were visualized after impregnation with EnHance spray (NEN
Life Science Products) and fluorography at HA Oligosaccharides Serve as Acceptors for rPmHAS--
In our
previous report, membrane preparations from recombinant E. coli containing rPmHAS protein had HA synthase activity as judged
by incorporation of radiolabel from UDP-[14C]GlcUA into
polymer when co-incubated with both UDP-GlcNAc and Mn2+ ion
(15). Based on the similarity at the amino acid level of PmHAS to some
lipopolysaccharide transferases, it seemed possible that HA
oligosaccharides would serve as acceptors for GlcUA and GlcNAc
transfer. The addition of unlabeled even-numbered HA tetramer (from
testicular hyaluronidase digests) to reaction mixtures with rPmHAS
stimulated incorporation of radiolabel from
UDP-[14C]GlcUA into HA polymer by ~20- to 60-fold in
comparison to reactions without oligosaccharides (Fig.
1). On the other hand, structurally similar sugars, heparosan pentamer or chitotetraose, did not stimulate incorporation of the radiolabel. The free monosaccharides GlcUA and
GlcNAc, either singly or in combination at concentrations of up to 100 mM, did not serve as acceptors; likewise, the
The activity of rPmHAS was dependent on the simultaneous incubation
with both UDP-sugar precursors and Mn2+ ion. The level of
incorporation was dependent on protein concentration, on HA
oligosaccharide concentration, and on incubation time (Fig. 2). HA synthesized in the presence or the
absence of HA oligosaccharides was sensitive to HA lyase (>95%
destroyed) and had a molecular weight of
Gel filtration chromatography analysis of reactions containing rPmHAS,
[3H]HA tetramer, UDP-GlcNAc, and UDP-GlcUA showed that
labeled polymers from ~0.5 to 5 × 104 Da (25-250
monosaccharides) were made (Fig. 3). In a
parallel reaction without UDP-GlcNAc, the elution profile of the
labeled tetramer was not altered.
The activity of the native PmHAS from P. multocida
membranes, however, was not stimulated by the addition of HA
oligosaccharides under similar conditions (not shown). It is likely
that native PmHAS enzyme has an attached or bound nascent HA chain that
was initiated in the bacterium before membrane isolation. The
recombinant enzyme, on the other hand, is expected to lack a nascent HA
chain as the E. coli host does not produce the UDP-GlcUA
precursor needed to make HA polysaccharide (10). Therefore, the
exogenous HA-derived oligosaccharide has access to the active site of
rPmHAS and can be elongated.
Sugar Transfer by rPmHAS Occurs at the Nonreducing End--
The
tetramer from ovine testicular hyaluronidase digests of HA terminates
at the nonreducing end with a GlcUA residue; this molecule served as an
acceptor for HA elongation by rPmHAS. On the other hand, the
Other Recombinant HASs Do Not Utilize HA Oligosaccharide
Acceptors--
Neither recombinant Group A HasA nor recombinant DG42
produced in yeast elongated HA-derived oligosaccharides into larger polymers. First, the addition of HA tetramer or a series of longer oligosaccharides neither stimulated nor inhibited the incorporation of
radiolabeled UDP-sugar precursors into HA by these enzymes significantly ( rPmHAS Elongates HA via Stepwise Addition of Single
Sugars--
TLC was utilized to monitor the PmHAS-catalyzed elongation
reactions containing 3H-labeled oligosaccharides and
various combinations of UDP-sugar nucleotides. Fig.
4A clearly shows that rPmHAS
elongated HA-derived tetramer by a single sugar unit if the next
appropriate UDP-sugar precursor was available in the reaction mixture.
GlcNAc derived from UDP-GlcNAc was added onto the GlcUA residue at the
nonreducing terminus of the tetramer acceptor to form a pentamer. On
the other hand, inclusion of only UDP-GlcUA did not alter the mobility
of the oligosaccharide. If both HA precursors were supplied, then various longer products were made. In parallel reactions, control membranes prepared from host cells with vector plasmid did not alter
the mobility of the radiolabeled HA tetramer under any circumstances (not shown). In similar analyses monitored by TLC, rPmHAS did not
utilize labeled chitopentaose as an acceptor (Fig. 4B).
HA-derived oligosaccharides with either GlcUA or GlcNAc at the
nonreducing terminus served as acceptors for rPmHAS (Fig.
5). Within 2 min, 2 to 6 sugar units were
added, and after 20 min, 9 to
The apparent GlcUA transfer rate of PmHAS is faster than the GlcNAc
transfer rate, as indicated by buildup of products terminating in GlcUA
at the reducing end in experiments with either acceptor at the 2-min
time point. This finding may be the result of the higher relative
affinity of PmHAS enzyme for the UDP-GlcUA substrate than UDP-GlcNAc,
as measured by the apparent Michaelis constant (Km)
in previous kinetic analyses (20 µM versus 75 µM, respectively; Ref. 9).
Potential Polymer Retention Mechanisms--
An intrinsic and
essential feature of polysaccharide synthesis is the repetitive
addition of sugar monomer units to the growing polymer. The
glycosyltransferase is expected to remain in association with the
nascent chain. This feature is particularly relevant for HA
biosynthesis, as the HA polysaccharide product in all known cases is
transported out of the cell; if the polymer was released, then the HAS
would not have another chance to elongate that particular molecule.
Three possible mechanisms for maintaining the growing polymer chain at
the active site of the enzyme are immediately obvious. First, the
enzyme possesses a carbohydrate polymer binding pocket or cleft.
Second, the nascent chain is covalently attached to the enzyme during
its synthesis. Third, the enzyme binds to the nucleotide base or the
lipid moiety of the precursor while the nascent polymer chain is still
covalently attached. Thus far, the molecular details of the vast
majority of polysaccharide synthases are lacking.
PmHAS and Acceptor Oligosaccharides--
The HAS activity of the
native PmHAS enzyme found in P. multocida membrane
preparations was not stimulated by addition of HA oligosaccharides;
theoretically, the endogenous nascent HA chain initiated in
vivo renders the exogenously supplied acceptor unnecessary.
However, recombinant PmHAS produced in an E. coli strain
that lacks the UDP-GlcUA precursor and, thus, lacks a nascent HA chain,
is able to bind and to elongate exogenous HA oligosaccharides. As
mentioned above, there are three likely means for a nascent HA chain to
be held at or near the active site. In the case of PmHAS, it appears
that a HA-binding site exists near or at the sugar transferase
catalytic site.
Defined oligosaccharides that vary in size and composition may be
utilized to discern the nature of the interaction between PmHAS and the
sugar chain. For example, it appears that the putative HA
polymer-binding pocket of PmHAS will bind and elongate at least an
intact HA trisaccharide (reduced tetramer). The monosaccharides GlcUA
or GlcNAc, however, even in combination at high concentration, are not
effective acceptors. Oligosaccharide binding to PmHAS appears to be
quite selective, because the heparosan pentamer, which only differs in
the glycosidic linkages from HA-derived oligosaccharides, does not
serve as an acceptor. Future studies will further examine the
structural requirements for the acceptor molecule as well as the
identity of the oligosaccharide-binding site on the PmHAS polypeptide.
The recombinant PmHAS enzyme, however, will produce HA chains without
the addition of exogenous HA-derived oligosaccharide, albeit at a lower
rate. Perhaps chain initiation is the rate-limiting step in HA
biosynthesis. Thus the stimulation of sugar incorporation into HA
chains observed in the presence of HA-derived acceptors is likely
to be due to the circumvention of the initial kinetic obstacle.
Acceptors and Other HA and Glycosaminoglycan
Synthases--
Previously no HA synthase had been shown to utilize an
exogenous acceptor or primer sugar. In an early study of a cell-free HA
synthesis system, preparations of native Group A streptococcal HAS were
neither inhibited nor stimulated by the addition of various HA
oligosaccharides, including the HA tetramer derived from testicular hyaluronidase digests (11). These membrane preparations were isolated
from cultures that were producing copious amounts of HA polysaccharide.
The cells were hyaluronidase-treated to facilitate handling. Therefore,
it is quite likely that the native streptococcal enzyme was isolated
with a small nascent HA chain attached to or bound to the protein much
as suspected in the case of native PmHAS. Theoretically, the existing
nascent chain formed in vivo would block the entry and
subsequent utilization of an exogenous acceptor by the isolated enzyme
in vitro. With the advent of molecularly cloned HAS genes,
it is possible to prepare virgin enzymes lacking a nascent HA chain if
the proper host is utilized for expression. The yeast S. cerevisiae, an organism whose genome has been totally sequenced,
does not possess the UDP-glucose dehydrogenase that is required for
UDP-GlcUA precursor synthesis. Nonetheless, the virgin yeast-derived
recombinant streptococcal or vertebrate enzymes did not utilize HA
acceptor oligosaccharides in our experiments in vitro.
Possible explanations for this finding are that the enzymes lack an
accessible binding site for the HA-derived acceptor chains tested, or
the enzymes utilize a different polymer retention mechanism.
Recently, it has been postulated that certain vertebrate HAS enzymes,
Xenopus DG42 and the Brachydanio zebrafish
homolog in particular, can produce chitin oligosaccharides under
certain conditions (23, 24). Another possibility forwarded was that chitin oligosaccharide primers are used to initiate HA chains, and
polymerization would occur at the nonreducing terminus (24). More
defined enzyme systems will be needed to address this difficult issue
in the vertebrate system. With respect to PmHAS, however, chitotetraose
and chitopentaose neither stimulated HA production nor served as
acceptors in our experiments.
In the case of the biosynthesis of the other glycosaminoglycan
polysaccharides, heparin and chondroitin, some details are available
(reviewed in Refs. 25 and 26). Both heparin and chondroitin are
synthesized by the addition of sugar units to the nonreducing end of
the polymer chain. In vivo, the glycosyltransferases initiate chain elongation on primer tetrasaccharides
(xylose-galactose-galactose-GlcUA) that are attached to serine residues
of proteoglycan core molecules. In vitro, enzyme extracts
transfer a single sugar to exogenously added heparin or chondroitin
oligosaccharides (26-29); unfortunately, the subsequent sugar of the
disaccharide unit is usually not added, and processive elongation to
longer polymers does not occur. Therefore it is likely that some
component is altered or missing in the in vitro system. In
the case of heparin biosynthesis, it is postulated that a single enzyme
transfers both GlcUA and GlcNAc sugars to the glycosaminoglycan chain
based on co-purification or expression studies (27, 28).
Recent work with the E. coli K5 KfiC enzyme, which
polymerizes heparosan, indicates that a single protein can transfer
both sugars to the nonreducing end of acceptor molecules in
vitro (30). Processive elongation, however, was not demonstrated
in these experiments; crude cell lysates transferred a single sugar to defined even- or odd-numbered oligosaccharides. However, their initial
mutagenesis experiments suggest that at least two independent sites
were involved in the transfer of the two monosaccharides (30).
Overview of Previous Models of Polysaccharide
Synthesis--
Several models describing various facets of the
biosynthesis of HA and other polysaccharides have been proposed in the
literature, but the lack of purified, stable enzymes and/or the
difficulty of monitoring early stages of the reaction have prevented
the rigorous testing of these hypotheses. The first theoretical model of HA biosynthesis based on direct logic proposed that two sites transferred the sugars individually from precursors to the nonreducing terminus of the nascent chain in an alternating fashion (31). Subsequent work by this laboratory on the Group A streptococcal HAS
enzyme gave corroborating data (11). On the other hand, two other
groups concluded that HA was extended by the addition of sugars to the
reducing end in experiments with native mammalian HAS preparations
(12-14). It is obvious that direct experiments with defined systems
utilizing purified enzyme will be necessary to address these issues.
Recently, general mechanistic models have been proposed for
Formation of the Disaccharide Repeat Structure of HA by
PmHAS--
We have found that recombinant PmHAS adds single
monosaccharides in a sequential fashion to the nonreducing termini of
the nascent HA chain. Elongation of HA polymers containing hundreds of
sugars was demonstrated in vitro. The simultaneous formation of the disaccharide repeat unit is not necessary for generating the
alternating structure of the HA molecule. The intrinsic specificity and
fidelity of each half-reaction (e.g. GlcUA added to a GlcNAc residue or vice versa) apparently is sufficient to synthesize authentic
HA chains.
A great technical benefit resulting from the alternating
disaccharide structure of HA is that the reaction may be dissected by controlling the availability of UDP-sugar nucleotides. By omitting or supplying precursors in a reaction mixture, the glycosyltransferase may be stopped and started at different stages of synthesis of the
heteropolysaccharide. In contrast, there is no facile way to control in
a stepwise fashion the glycosyltransferase enzymes that produce
important homopolysaccharides such as chitin, cellulose, starch, and
glycogen. The lessons learned with PmHAS in the future, however, may be
applicable to the study of other enzyme systems.
Two Classes of HA Synthases--
It has been established that one
polypeptide species transfers both GlcUA and GlcNAc during HA
biosynthesis in all known cases (7, 8, 10, 15, 16, 22), but at least
two evolutionary paths may have led to the creation of HA synthases. I
propose that two distinct classes of enzyme exist based on differences in the amino acid sequences, the predicted polypeptide topology in the
membrane bilayer, and the putative reaction pathway. Class I HASs would
include the previously described streptococcal, viral, and vertebrate
enzymes. At present, P. multocida PmHAS is the only known
member of the Class II HA synthase. In the near future, it will be
interesting to examine and to compare the reaction mechanisms of the
glycosaminoglycan synthases and other
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
(1,4)GlcUA-
(1,3)GlcNAc repeats. In vertebrates, HA
is a major structural element of the extracellular matrix and plays
roles in adhesion and recognition (1). HA has a high negative charge
density and numerous hydroxyl groups; therefore, the molecule assumes
an extended, hydrated conformation in solution. The viscoelastic
properties of cartilage and synovial fluid are in part the result of
the physical properties of the HA polysaccharide. HA also interacts
with proteins such as CD44, RHAMM, and fibrinogen, thereby influencing
many natural processes such as angiogenesis, cancer, cell motility,
wound healing, and cell adhesion (2).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-mercaptoethanol was
substituted for thioglycollate throughout the procedure. PmHAS was
assayed in 50 mM Tris, pH 7.2, 20 mM
MnC12, and UDP-sugars (UDP-[14C]GlcUA, 0.3 Ci/mmol (NEN Life Science Products) and UDP-GlcNAc) at 30 °C. The
reaction products were analyzed by various chromatographic methods as
described below. Membrane preparations containing other recombinant HAS
enzymes, Group A streptococcal HasA or Xenopus DG42 produced
in the yeast Saccharomyces cerevisiae, were prepared as
described previously (16).
GlcUA residue at the nonreducing
terminus of each fragment (18). For further purification and desalting,
some preparations were subjected to gel filtration with P-2 resin
(Bio-Rad) in 0.2 M ammonium formate and lyophilization.
Odd-numbered HA oligosaccharides
(GlcNAc(GlcUA-GlcNAc)n) ending in a GlcNAc residue
were prepared by mercuric acetate treatment of partial HA digests
generated by HA lyase (n = 2-7; gift of Dr. G. Sugumaran; Ref. 19). The masses of the HA oligosaccharides were
verified by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Sugars in water were mixed with an equal volume of 5 mg/ml 6-azo-2-thiothymine in 50% acetonitrile, 0.1%
trifluoroacetic acid and rapidly air-dried on the target plate. The
negative ions produced by pulsed nitrogen laser irradiation were
analyzed in linear mode (20-kV acceleration; Perceptive Voyager®).
(1,4)GlcNAc-
(1,4)GlcUA)2-
(1,4)GlcNAc (gift of
Dr. G. Sugumaran; Ref. 20); this carbohydrate has the same composition
as HA, but the glycosidic linkages between the monosaccharides are
different. The chitin-derived oligosaccharides, chitotetraose and
chitopentaose, are
(1,4)GlcNAc polymers made of 4 or 5 monosaccharides, respectively (gift of Dr. P. Robbins).
80 °C.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-methyl glycosides of these sugars did not stimulate HAS activity (not shown).

View larger version (12K):
[in a new window]
Fig. 1.
HA tetramer stimulates rPmHAS
polymerization. A series of reactions containing rPmHAS (30 µg
of total membrane protein) were incubated with
UDP-[14C]GlcUA (2 × 104 dpm, 120 µM) and UDP-GlcNAc (450 µM) in assay buffer
(50-µl reaction volume) in the presence of no added sugar
(none) or various oligosaccharides (4 µl of HA tetramer
(HA4), 4 µg of unsaturated HA
tetramer and
hexamer
(unsHA4/6), 50 µg of chitotetraose (chito4), 20 µg of heparosan pentamer (hep5)). After 1 h, the
reactions were analyzed by descending paper chromatography.
Incorporation of radiolabel from UDP-[14C]GlcUA into high
molecular weight HA is shown. Only intact tetramer (HA4)
served as an acceptor. Reactions with heparosan and
chitooligosaccharides, as well as GlcNAc and/or GlcUA (not shown),
incorporated as much radiolabel as parallel reactions with no
acceptor.
1-5 × 104
Da (~50-250 monosaccharides). No requirement for a lipid-linked intermediate was observed as neither bacitracin (0.5 mg/ml) nor tunicamycin (0.2 mg/ml) altered the level of incorporation in comparison to parallel reactions with no inhibitor.

View larger version (15K):
[in a new window]
Fig. 2.
Time course of HA polymerization; effect of
HA oligosaccharides. Two parallel reactions containing rPmHAS with
even-numbered HA oligosaccharides (105 µg of membrane protein/point
with a mixture of HA hexamer, octamer, and decamer, 4.4 µg total
(solid circles)) or 6-fold more rPmHAS without
oligosaccharide acceptor (630 µg of protein/point (open
circles)) were compared. The enzyme preparations were added to
prewarmed reaction mixtures containing UDP-[14C]GlcUA
(240 µM, 6×104 dpm/point) and UDP-GlcNAc
(600 µM) in assay buffer. At various times,
50-µl aliquots were withdrawn, terminated, and analyzed by paper
chromatography. The exogenously supplied acceptor accelerated the bulk
incorporation of sugar precursor into polymer product by PmHAS, but the
acceptor was not absolutely required.

View larger version (17K):
[in a new window]
Fig. 3.
HA tetramer elongation into larger polymers
by rPmHAS. Gel filtration analysis on Sephacryl S-200 (20-ml
column, 0.7-ml fractions) shows that rPmHAS makes HA polysaccharide
using HA tetramer acceptor and UDP-sugars. Dextrans of
80 kDa (~400
monosaccharides) elute in the void volume (Vo,
arrow). The starting tetramer elutes in the included volume
(Vi, arrow). Membranes (190 µg of total
protein), UDP-GlcUA (200 µM), UDP-GlcNAc (600 µM), and radiolabeled [3H]HA tetramer
(1.1 × 105 dpm) were incubated for 3 h before
gel filtration (solid squares). As a negative control, a
parallel reaction containing all the components except for UDP-GlcNAc
was analyzed (open squares). The small primer was elongated
into higher molecular weight product if both precursors were
supplied.
tetramer and
hexamer oligosaccharides produced by the action of
Streptomyces HA lyase did not stimulate HA polymerization (Fig. 1, unsHA4/6). As a result of the lyase eliminative
cleavage, the terminal unsaturated sugar is missing the C4 hydroxyl of
GlcUA (18), which would normally be extended by the HA synthase. The lack of subsequent polymerization onto this terminal unsaturated sugar
is analogous to the case of dideoxynucleotides causing chain termination if present during DNA synthesis. A closed pyranose ring at
the reducing terminus was not required by PmHAS, since reduction with
borohydride did not effect the ability of the HA tetramer to serve as
an acceptor; this finding also allowed the use of borotritide labeling
to monitor the fate of oligosaccharides.
±5% control value). In parallel experiments, the HAS
activity of HasA or DG42 were not affected by the addition of
chitin-derived oligosaccharides (data not shown). Second, the recombinant enzymes did not elongate radiolabeled HA tetramer in the
presence of UDP-sugars (Table I). These
same preparations of enzymes, however, were highly active in the
conventional HAS assay in which radiolabeled UDP-sugars were
polymerized into HA.
Acceptor use of various recombinant HA synthases

View larger version (22K):
[in a new window]
Fig. 4.
TLC analysis of PmHAS extension of HA
tetramer. Panel A, radiolabeled HA tetramer
(HA4, 8 × 103 dpm 3H) with a
GlcUA at the nonreducing terminus was incubated with various
combinations of UDP-sugars (360 µM UDP-GlcUA
(A); 750 µM UDP-GlcNAc (N), no
UDP-sugar (O)), and rPmHAS (55 µg of membrane protein) in
assay buffer for 60 min. The reactions (7 µl total) were terminated
by heating at 95 °C for 1 min and clarified by centrifugation.
Portions (2.5 µl) of the supernatant were spotted onto the
application zone of a silica TLC plate and developed with solvent
(1.25:1:1). The beginning of the analytical layer is marked with an
arrow. The positions of odd-numbered HA oligosaccharides
(S lane) are marked as number of monosaccharide units. This
autoradiogram (4-day exposure) shows the single addition of a GlcNAc
sugar onto the HA tetramer acceptor to form a pentamer when only the
subsequent precursor is supplied (N). The mobility of the
labeled tetramer is unchanged if only the inappropriate precursor,
UDP-GlcUA (A) or no UDP-sugar (0) is present. If
both UDP-sugars are supplied, then a ladder of products with sizes of
5, 7, 9, 11, and 13 sugars is formed (+AN). Panel
B, in a parallel experiment, chitopentaose (8 × 104 dpm 3H (Chito5)) was tested as
an acceptor substrate. Under no condition was this structurally related
molecule extended by rPmHAS.
15 units were added. In the experiments
with HA tetramer and both sugars at the 20-min time point, a ladder of
even- and odd-numbered products is produced. Therefore, in combination
with the results of the single UDP-sugar experiments, it appears that PmHAS transfers individual monosaccharides sequentially during the
polymerization reaction.

View larger version (19K):
[in a new window]
Fig. 5.
TLC analysis of the early stages of HA
elongation. Radiolabeled HA pentamer (5×103 dpm
3H (HA5)) or HA tetramer (25×103
dpm 3H (HA4)) was incubated with rPmHAS and
various combinations of UDP-sugars (as in Fig. 4) for 2 or 20 min.
Portions (1.5 µl) of the supernatant were spotted onto the TLC plate
and developed in 1.5:1:1 solvent. This autoradiogram (1-month exposure)
shows the single addition of a sugar onto an acceptor when only the
appropriate precursor is supplied (HA4, N lane
and HA5, A lane). If both UDP-sugars are supplied
(+AN lanes), then a ladder of products with final sizes of
6, 8, and 10 sugars is formed from either HA4 or HA5 in 2 min. After 20 min, a range of odd- and even-numbered product sugars are observed in
reactions with HA4 and both UDP-sugars. In the 20-min reaction with HA5
and both UDP-sugars, the HA products are so large that they do not
migrate from the application zone.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-glycosyltransferases that synthesize polysaccharides (32, 33). The
hypotheses were based loosely on the putative mechanism of carbohydrate
hydrolases that cleave polymer chains, but in the case of synthesis,
the reaction would run in the reverse direction. It was also proposed
in both models that three binding sites for sugar-nucleotides and/or
sugars are utilized to synthesize the polymer in a processive fashion.
The directionality of chain synthesis was undecided until electron
microscopy and x-ray diffraction data from cellulose fibrils protruding
from Acetobacter bacteria implied that new sugars were added
to the nonreducing terminus (33). In these models, the two
monosaccharides of the disaccharide repeat are simultaneously added
onto the polymer chain bound to the enzyme. This reaction pathway
allows the formation of
-linked bonds from
-linked UDP-sugars by
an inversion mechanism and removes the need for the polymer chain or
the protein to rotate during the elongation reaction. This latter
feature was invoked in part to eliminate topological problems during
the formation of insoluble cellulose fibrils (32). The models were then
extended further to other
-linked polysaccharide synthases due to
the similarities of certain putative domains and/or motifs at the
protein sequence level (32, 33).
-glycosyltransferases in more detail.
| |
ACKNOWLEDGEMENTS |
|---|
I thank Bruce Baggenstoss, Tom Pugh, and the National Science Foundation Experimental Program to Stimulate Competitive Research (EPSCoR) Oklahoma Biotechnology Network Laser Mass Spectrometry facility for mass spectra of the sugars, Drs. Phillips Robbins and Geetha Sugumaran for the gifts of oligosaccharides, and Drs. Gillian Air, William Canfield, Richard Cummings, and Paul Weigel for helpful comments on the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grant GM56497 and the National Science Foundation Grant MCB-9876193.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of
Biochemistry and Molecular Biology, University of Oklahoma Health
Sciences Center, 940 Stanton L. Young Blvd., Oklahoma City, OK 73104. Tel.: 405-271-2227; Fax: 405-271-3092; E-mail:
paul-deangelis@OUHSC.edu.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: HA, hyaluronan or hyaluronic acid; GlcUA, glucuronic acid; GlcNAc, N-acetylglucosamine; HAS, HA synthase; PmHAS, P. multocida HAS; rPmHAS, recombinant PmHAS.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Laurent, T. C., and Fraser, J. R. E. (1992) FASEB J. 6, 2397-2404[Abstract] |
| 2. | Knudson, C. B., and Knudson, W. (1993) FASEB J. 7, 1233-1241[Abstract] |
| 3. | Carter, G. R., and Annau, E. (1953) Am. J. Vet. Res. 14, 475-478[Medline] [Order article via Infotrieve] |
| 4. | Kass, E. H., and Seastone, C. V. (1944) J. Exp. Med. 79, 319-330[Abstract] |
| 5. | Harmon, B. G., Glisson, J. R., Latimer, K. S., Steffens, W. L., and Nunnally, J. C. (1991) Am. J. Vet. Res. 52, 1507-1511[Medline] [Order article via Infotrieve] |
| 6. |
Wessels, M. R.,
Moses, A. E.,
Goldberg, J. B.,
and DiCesare, T. J.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
8317-8321 |
| 7. |
DeAngelis, P. L.,
Jing, W.,
Graves, M. V.,
Burbank, D. E.,
and van Etten, J. L.
(1997)
Science
278,
1800-1804 |
| 8. |
Weigel, P. H.,
Hascall, V. C.,
and Tammi, M.
(1997)
J. Biol. Chem.
272,
13997-14000 |
| 9. | DeAngelis, P. L. (1996) Biochemistry 35, 9768-9771[CrossRef][Medline] [Order article via Infotrieve] |
| 10. |
DeAngelis, P. L.,
Papaconstantinou, J.,
and Weigel, P. H.
(1993)
J. Biol. Chem.
268,
19181-19184 |
| 11. |
Stoolmiller, A. C.,
and Dorfman, A.
(1969)
J. Biol. Chem.
244,
236-246 |
| 12. | Prehm, P. (1983) Biochem. J. 211, 181-189[Medline] [Order article via Infotrieve] |
| 13. | Asplund, T., Brinck, J., Suzuki, M., Briskin, M. J., and Heldin, P. (1998) Biochim. Biophys. Acta 1380, 377-388[Medline] [Order article via Infotrieve] |
| 14. | Prehm, P. (1983) Biochem. J. 211, 191-198[Medline] [Order article via Infotrieve] |
| 15. |
DeAngelis, P. L.,
Jing, W.,
Drake, R. R.,
and Achyuthan, A. M.
(1998)
J. Biol. Chem.
273,
8454-8458 |
| 16. |
DeAngelis, P. L.,
and Achyuthan, A. M.
(1996)
J. Biol. Chem.
271,
23657-23660 |
| 17. | Taylor, K. A., and Buchanan-Smith, J. G. (1992) Anal. Biochem. 201, 190-196[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Ohya, T., and Kaneko, Y. (1970) Biochim. Biophys. Acta 198, 607-609[Medline] [Order article via Infotrieve] |
| 19. | Ludwigs, U., Elgavish, A., Esko, J. D., Meexan, E., and Roden, L. (1987) Biochem. J. 245, 795-804[Medline] [Order article via Infotrieve] |
| 20. | Lidholt, K., and Lindahl, U. (1992) Biochem. J. 287, 21-29 |
| 21. | Hall, N. A., and Patrick, A. D. (1989) Anal. Biochem. 178, 378-384[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | DeAngelis, P. L, and Weigel, P. H. (1994) Biochemistry 33, 9033-9039[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Semino, C. E.,
and Robbins, P. W.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
3498-3501 |
| 24. |
Semino, C. E.,
Specht, C. A.,
Raimondi, A.,
and Robbins, P. W.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
4548-4553 |
| 25. | Roden, L. (1980) in The Biochemistry of Glycoproteins and Proteoglycans (Lennarz, W. J., ed) , pp. 267-371, Plenum Publishing Corp., New York |
| 26. | Lidholt, K. (1997) Biochem. Soc. Trans. 25, 866-870[Medline] [Order article via Infotrieve] |
| 27. |
Lind, T.,
Lindahl, U.,
and Lidholt, K.
(1993)
J. Biol. Chem.
268,
20705-20708 |
| 28. |
Lind, T.,
Tufaro, F.,
McCormick, C.,
Lindahl, U.,
and Lidholt, K.
(1998)
J. Biol. Chem.
273,
26265-26268 |
| 29. |
Sugumaran, G.,
Katsman, M.,
Sunthankar, P.,
and Drake, R. R.
(1997)
J. Biol. Chem.
272,
14399-14403 |
| 30. |
Griffiths, G.,
Cook, N. J.,
Gottfridson, E.,
Lind, T.,
Lidholt, K.,
and Roberts, I. S.
(1998)
J. Biol. Chem.
273,
11752-11757 |
| 31. |
Markovitz, A.,
Cifonelli, J. A.,
and Dorfman, A.
(1959)
J. Biol. Chem.
234,
2343-2350 |
| 32. |
Saxena, I. M.,
Brown, R. M.,
Fevre, M.,
Geremia, R. A.,
and Henrissat, B.
(1995)
J. Bacteriol.
177,
1419-1424 |
| 33. |
Koyama, M.,
Helbert, W.,
Imai, T.,
Sugiyama, J.,
and Henrissat, B.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
9091-9095 |
This article has been cited by other articles:
![]() |
M. Belanova, P. Dianiskova, P. J. Brennan, G. C. Completo, N. L. Rose, T. L. Lowary, and K. Mikusova Galactosyl Transferases in Mycobacterial Cell Wall Synthesis J. Bacteriol., February 1, 2008; 190(3): 1141 - 1145. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Weigel and P. L. DeAngelis Hyaluronan Synthases: A Decade-plus of Novel Glycosyltransferases J. Biol. Chem., December 21, 2007; 282(51): 36777 - 36781. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Tracy, F. Y. Avci, R. J. Linhardt, and P. L. DeAngelis Acceptor Specificity of the Pasteurella Hyaluronan and Chondroitin Synthases and Production of Chimeric Glycosaminoglycans J. Biol. Chem., January 5, 2007; 282(1): 337 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Williams, K. M. Halkes, J. P. Kamerling, and P. L. DeAngelis Critical Elements of Oligosaccharide Acceptor Substrates for the Pasteurella multocida Hyaluronan Synthase J. Biol. Chem., March 3, 2006; 281(9): 5391 - 5397. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Tlapak-Simmons, C. A. Baron, R. Gotschall, D. Haque, W. M. Canfield, and P. H. Weigel Hyaluronan Biosynthesis by Class I Streptococcal Hyaluronan Synthases Occurs at the Reducing End J. Biol. Chem., April 1, 2005; 280(13): 13012 - 13018. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bodevin-Authelet, M. Kusche-Gullberg, P. E. Pummill, P. L. DeAngelis, and U. Lindahl Biosynthesis of Hyaluronan: DIRECTION OF CHAIN ELONGATION J. Biol. Chem., March 11, 2005; 280(10): 8813 - 8818. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. DeAngelis and C. L. White Identification of a Distinct, Cryptic Heparosan Synthase from Pasteurella multocida Types A, D, and F J. Bacteriol., December 15, 2004; 186(24): 8529 - 8532. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Jing and P. L. DeAngelis Synchronized Chemoenzymatic Synthesis of Monodisperse Hyaluronan Polymers J. Biol. Chem., October 1, 2004; 279(40): 42345 - 42349. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hoshi, H. Nakagawa, S. Nishiguchi, K. Iwata, K. Niikura, K. Monde, and S.-I. Nishimura An Engineered Hyaluronan Synthase: CHARACTERIZATION OF RECOMBINANT HUMAN HYALURONAN SYNTHASE 2 EXPRESSED IN ESCHERICHIA COLI J. Biol. Chem., January 23, 2004; 279(4): 2341 - 2349. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Jing and P. L. DeAngelis Analysis of the two active sites of the hyaluronan synthase and the chondroitin synthase of Pasteurella multocida Glycobiology, October 1, 2003; 13(10): 661 - 671. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. DeAngelis, L. C. Oatman, and D. F. Gay Rapid Chemoenzymatic Synthesis of Monodisperse Hyaluronan Oligosaccharides with Immobilized Enzyme Reactors J. Biol. Chem., September 12, 2003; 278(37): 35199 - 35203. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Akita, T. Ishimizu, T. Tsukamoto, T. Ando, and S. Hase Successive Glycosyltransfer Activity and Enzymatic Characterization of Pectic Polygalacturonate 4-alpha -Galacturonosyltransferase Solubilized from Pollen Tubes of Petunia axillaris Using Pyridylaminated Oligogalacturonates as Substrates Plant Physiology, September 1, 2002; 130(1): 374 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. DeAngelis and C. L. White Identification and Molecular Cloning of a Heparosan Synthase from Pasteurella multocida Type D J. Biol. Chem., February 22, 2002; 277(9): 7209 - 7213. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Tammi, A. J. Day, and E. A. Turley Hyaluronan and Homeostasis: A Balancing Act J. Biol. Chem., February 8, 2002; 277(7): 4581 - 4584. [Full Text] [PDF] |
||||
![]() |
L. Peng, Y. Kawagoe, P. Hogan, and D. Delmer Sitosterol-beta -glucoside as Primer for Cellulose Synthesis in Plants Science, January 4, 2002; 295(5552): 147 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. DeAngelis Microbial glycosaminoglycan glycosyltransferases Glycobiology, January 1, 2002; 12(1): 9R - 16R. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Charnock, B. Henrissat, and G. J. Davies Three-Dimensional Structures of UDP-Sugar Glycosyltransferases Illuminate the Biosynthesis of Plant Polysaccharides Plant Physiology, February 1, 2001; 125(2): 527 - 531. [Full Text] |
||||
![]() |
W. Jing and P. L. DeAngelis Dissection of the two transferase activities of the Pasteurella multocida hyaluronan synthase: two active sites exist in one polypeptide Glycobiology, September 1, 2000; 10(9): 883 - 889. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Cartee, W. T. Forsee, J. S. Schutzbach, and J. Yother Mechanism of Type 3 Capsular Polysaccharide Synthesis in Streptococcus pneumoniae J. Biol. Chem., February 11, 2000; 275(6): 3907 - 3914. [Abstract] [Full Text] [PDF] |
||||